How would you characterize the following changes to your anemia management practice compared with 5 years ago?
Select one per category
Amount of clinical focus on anemia management
Stage at which anemia workup is initiated
Your approach to iron optimization before erythropoiesis-stimulating agents (ESA)
Why has this changed over the past 5 years?
Frequency that iron optimization alone can resolve anemia
Number of patients reaching later-stage CKD requiring an ESA
Why has this changed over the past 5 years?
Transfusion frequency
Why has the transfusion frequency increased over the past 5 years?
Kidney transplants
At what hemoglobin level do you typically initiate an anemia workup in your patients with kidney disease?
For ESKD patients:
Enter number
How does this threshold compare with 5 years ago?
For CKD patients:
Enter number
How does this threshold compare with 5 years ago?
Over the past 5 years, how has your iron management approach changed?
Select all that apply
How have these changes in your iron management affected ESA use in your practice?
Select one
In your practice, what newer therapy/therapies have impacted CKD progression or anemia management?
Enter therapy(s) and rate each impact
Rate how "@therapy@" has impacted the following variables:
Substantially Decreased
⇔
Substantially Increased
Rate of CKD progression
Prevalence of anemia
Frequency of IV iron use
Frequency of ESA initiation
Average dose of ESA
Rate how "@therapy@" has impacted the following variables:
Substantially Decreased
⇔
Substantially Increased
Rate of CKD progression
Prevalence of anemia
Frequency of IV iron use
Frequency of ESA initiation
Average dose of ESA
Approximately what proportion of your dialysis patients currently receives ESA therapy?
Enter numbers
Institutional dialysis
Home modalities
Current proportion:
Proportion from 5 years ago:
Approximately what proportion of your CKD patients currently receives ESA therapy?
Enter numbers
What hemoglobin level do you typically use to initiate ESA therapy in dialysis patients with adequate iron repletion?
For Hemodialysis (HD):
Enter numbers
How does this threshold compare with 5 years ago?
Select one
For Home modalities:
Enter numbers
How does this threshold compare with 5 years ago?
Select one
What hemoglobin maintenance level do you typically target in ESKD patients receiving ESA therapy?
Enter number
How does this threshold compare with 5 years ago?
Select one
What hemoglobin level do you typically use to initiate ESA therapy in CKD patients with adequate iron repletion?
Enter number
How does this threshold compare with 5 years ago?
Select one
What hemoglobin maintenance level do you typically target in CKD patients receiving ESA therapy?
Enter number
How does this threshold compare with 5 years ago?
Select one
What is your preferred first-line ESA agent for ESKD patients?
Select one
What is your preferred first-line ESA agent for CKD patients?
Select one
Do you currently use hemodiafiltration (HDF)?
Select one
Approximately what proportion of your dialysis patients receive HDF vs conventional hemodialysis?
Enter percentage for each
Compared with conventional hemodialysis, have you observed any difference in hemoglobin levels or ESA requirements in patients receiving HDF?
Select one
To what extent are each of the following COVID-19–related factors still influencing your clinical practice today?
Select one for each
No longer a factor
<=>
Significant ongoing impact
Disruption to CKD referral pipeline
Backlog of more advanced or complex referrals
Nursing staff shortage
Physician staff shortage
Shift to telehealth visits